Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve
Original notice title
Belgium – Research and experimental development services – Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Rapid deployment of investigational vaccines during outbreaks requires pre-established logistics, regulatory approvals...
Investigational vaccines are subject to evolving EU and international regulations. Changes in clinical trial or manufac...
Submission deadline in 10 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- EUR 16M estimated value
- Services contract
- 1 lot
- Duration 48 MONTH
- Establish and maintain a reserve of investigational Filovirus vaccines (Ebola Sudan, Ebola Bundibugyo, Marburg) in the EU.
- Ensure rapid deployment of investigational doses during outbreaks subject to conditions.
Show full summary
This open tender by the Health and Digital Executive Agency (HaDEA) seeks to establish a pilot EU-based reserve of investigational Filovirus vaccines (against Ebola Sudan, Ebola Bundibugyo, and Marburg) to ensure clinical trial preparedness. The contract involves maintaining and rapidly deploying candidate vaccines during outbreaks. The single lot has an estimated value of €16,000,000 (EU-funded) and a duration of 48 months. Award is based on quality (80%) and price (20%). Submission deadline is 25 August 2026. Key documents and eligibility details are not specified in the provided data.
Risks
Rapid deployment of investigational vaccines during outbreaks requires pre-established logistics, regulatory approvals...
Investigational vaccines are subject to evolving EU and international regulations. Changes in clinical trial or manufac...
Submission deadline in 10 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderers must have the capability to manufacture, store, and maintain investigational vaccines under appropriate conditions.
- Rapid deployment mechanism must be in place for outbreak scenarios.
- Compliance with EU regulations and funding requirements (EU4Health programme).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Brussels, BEL
Website
Identifier
HADEA
Activity
General public services
Lots (1)
LOT-0001
Clinical Trial Readiness through the Establishment of a Pilot Filovirus Investigational Vaccine Reserve
This lot covers the establishment, piloting, and maintenance of an investigational reserve of Filovirus candidate vaccines (SUDV, BDBV, MARV) for rapid deployment in outbreak-associated clinical trials. Tenderers must ensure rapid deployment under specific conditions (outbreak occurrence and HAEA consent).
EUR 16M
Estimated value
Duration
Category
Award Criteria
Deadline
Award details
Please consult the procurement documents.
Additional CPV codes
Value note
Show original TED data
Original TED description
This call for tenders aims to ensure clinical trial preparedness for Filovirus outbreaks through the establishment of an EU-based reserve of investigational vaccines as a critical preparedness measure, given the sporadic yet high-consequence nature of these pathogens. Specifically, the call aims to establish, pilot and maintain an investigational reserve of Filovirus candidate vaccines against Ebola Sudan (SUDV), Ebola Bundibugyo (BDBV) and/or Marburg (MARV), which – in case of an outbreak – could be used to advance their development by embedding them in outbreak-associated clinical trials, facilitated through international agreements and frameworks to support such preparedness. These provisions will allow for the rapid deployment of candidate vaccines for their later-stage development. Tenderers will further have to ensure the rapid deployment of the investigational doses, subject to specific conditions being met (such as the occurrence of an outbreak and the expressed consent of the Contracting Authority).
Procurement Details
- Publication date
- 02 Jun 2026
- Languages
- English, Bulgarian
Reference metadata
- Legal basis
- 32024R2509
Reference IDs
- Tender ID
- 381062-2026
Documents (2)
Similar tenders
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Romania – Street-cleaning and sweeping services – Acord cadru de prestare a serviciilor de delegare a activităților de măturat, spălat, stropit si întreținerea căilor publice și activități de curățare și transport al zăpezii de pe căile publice și menținerea în funcțiune a acestora pe timp de polei sau îngheț, pe timp de iarnă din cadrul serviciului de salubrizare a orașului Negrești Oaș
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
France – Insurance services – MARCHE DE SERVICES EN ASSURANCE
Spain – Building-cleaning services – Servicios de limpieza en Centros de Sevilla, Murcia y Galicia, de la Agencia Estatal Consejo Superior de Investigaciones Científicas.
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
65 / 100
Risk factors
Rapid deployment of investigational vaccines during outbreaks requires pre-established logistics, regulatory approvals...
Investigational vaccines are subject to evolving EU and international regulations. Changes in clinical trial or manufac...
Submission deadline in 10 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications